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Ring-closing olefin metathesis reactions are used to create intra-molecularly ring closed peptides or inter-molecularly ring-closed peptide dimers based on a designed amyloid peptide sequence. The uncrosslinked peptide self-assembles into high aspect ratio nanotubes, however ring-closing leads to the formation of fibrillar and twisted/helical ribbon structures.












Scheme 1. Structures of peptide I and alkene-bridged peptides II, III.
The design of the peptide containing two allyl- functionalized aspartic acid residues, D(All) is shown in Scheme 1. The peptide was designed based on the KLVFFAE sequence A(16-22) from the amyloid beta peptide.11-13 This contains the core KLVFF sequence in amyloid fibrillisation and has been exploited as the basis for a series of designed peptides under investigation in our group.14-18 The sequence was modified to EAFFD(All)D(All)VVLK, peptide I. The use of the allyl-functionalized glutamic acid residues, D(All), as cross-linkable residues, was motivated by the commercial availability of the corresponding Fmoc-D(All) amino acid. Peptide Ac-KLVFFAE-NH2 has been shown to self-assemble into nanotubes in pH 2 acetonitrile/H2O solutions.12, 19 Incorporating the two allyl ester aspartic acid residues as well as an additional Val residue in peptide I (also with a reverse sequence) still leads to nanotube formation, and we were therefore able, uniquely, to investigate the influence of metathesis ring-closing on peptide nanotube self-assembly. 
The peptide E(OtBu)AFFD(All)D(All)VVLK(Boc) containing cross-linkable allyl-functionalized aspartic acid residues [D(OAll)] was prepared by solid phase peptide synthesis methods. Deprotection afforded peptide I. Cross-linking reactions were performed with the peptide on resin20, 21 using an olefin metathesis reaction using a second generation Hoyveda-Grubbs catalyst as described in the Supporting Information. Two products, peptides II and III were obtained from this peptide. Peptide II is an intra-molecularly ring-closed peptide, while III is a ring-closed peptide dimer. In addition, byproducts associated with the peptide I lacking the A residue were also identified and labelled IV, V. These are discussed further in the Supporting Information.

In the following, we investigate the self-assembly of II and III compared to the uncross-linked peptide I using cryogenic transmission electron microscopy (cryo-TEM) and small angle x-rays scattering (SAXS) to probe the nanostructure in aqueous solution; X-ray diffraction is further employed to elucidate details of the molecular packing. Unexpectedly, despite the steric constraints induced by ring-closing, the formation of amyloid fibrils is observed for II and III.













Figure 1. Peptide I forms nanotubes in aqueous solution. (a) Cryo-TEM image obtained from a 2.4 wt% solution, (b) Integrated SAXS intensity profile (black points) and WAXS profile (blue points) along with calculated low q form factor (red line) measured for a 2 wt% solution. A similar profile was observed for an 0.5 wt% solution, (c) 2D-SAXS pattern from the same 2 wt% sample, showing alignment of nanotubes along the (horizontal) flow direction.

At high q, a series of Bragg peaks are observed that are due to the configuration of the peptides within the nanotube walls (to be discussed shortly). In addition, the WAXS profile measured simultaneously (Fig.1b and expanded in SI Fig.10) contains peaks assigned to the -sheet structure of the peptides, specifically sharp peaks due to the -strand spacing (0.47 nm) and the -sheet stacking distance (1.06 nm) as well as several additional reflections. Spontaneous alignment of peptide nanotubes upon transfer into the capillary flow-through cell used for SAXS was observed, as revealed by the two-dimensional SAXS profile in Fig.1c. This shows intensity maxima along the meridional (vertical) direction, i.e. perpendicular to the horizontal flow direction. These maxima are the primary form factor peaks in Fig.1b.

The influence of cross-linking (intra-molecular in the case of II, inter-molecular dimerization in the case of III) was examined by cryo-TEM and SAXS. Fig.2 presents cryo-TEM images. Peptide II does not self-assemble at 0.5 wt% (Fig. 2a,b). However, at higher concentration (2 wt%) -sheet formation is observed by FTIR (SI Fig.11) and fibrils are noted in cryo-TEM images (SI Fig.12). In contrast, cryo-TEM indicates that Peptide III forms a mixture of straight fibrils and shorter irregular aggregates (Fig.2c,d) even at 0.5 wt%. This is supported by FTIR (SI Fig.11) and negative stain TEM (SI Fig.13). For the fibrils, the average diameter is (6.3 ± 0.5) nm.  The cryo-TEM images therefore reveal that neither II nor III form the nanotube structure of the uncross-linked parent peptide I.

To complement real-space imaging, and to provide an in situ probe of nanostructure over a larger volume than cryo-TEM, SAXS (and WAXS) was performed. Fig.3 shows representative data. In contrast to the data shown in Fig.1, nanotube form factor oscillations are not observed for solutions of either peptide II or III (Fig.3). These intensity profiles result from fibril self-assembly – the form factor maxima at q = 0.6 nm-1 (peptide II) or q = 1.4 nm-1 (peptide III) are associated with the diameters of the fibrils shown in Fig.2.
Figure 2. Cryo-TEM images. (a,b) Peptide II, 0.5 wt% in H2O, (c,d) Peptide III, 0.25 wt% in H2O. 





Figure 3. SAXS (and selected WAXS) data for peptide II and III in 0.5 wt% aqueous solutions. The inset shows an enlargement of the WAXS profiles (in box) with linear intensity and q scales.
To further investigate nanostructure, X-ray diffraction was performed on dried stalks. Representative images are shown in SI Fig.14. SI Fig.15 shows typical intensity profiles from equatorial sector averages for peptide I and peptide II. This highlights certain features associated with the nanotube structure of peptide I, in particular the presence of peaks at d = 0.55 nm and d = 0.45 nm which are absent for peptide II, the XRD pattern for which shows classical “cross-” pattern features, i.e. the 1.1 nm and 0.48 nm spacings (the same features were observed for peptide III, data not shown). The peaks observed for peptide I were previously observed in oriented X-ray diffraction patterns (obtained by flow alignment) for the heptapeptide A6K which forms nanotubes in concentrated aqueous solution.22 A model for the origin of these peaks was presented based on the helical wrapping of peptide dimers (with a two-residue offset between adjacent dimers). An additional feature noted in the fibre XRD is a d = 1.8 nm peak for both peptides. For peptide I, it may be noted that a strong meridional reflection presumably associated with the -strand spacing, is shifted such that the spacing is larger than usual, d = 0.49 nm. The d = 0.45 nm peak is only present as a shoulder. The d = 0.39 nm peak for peptide I is sharper and more intense than the corresponding d = 0.38 nm peak observed for peptide II. This peak is associated with the C – Cbackbone spacing. 22






Figure 4. Simulated conformations for (a) Peptide II, (b) Peptide III.
In summary, ring-closing metathesis can be used to create an intra-molecularly folded U-shaped peptide, whereas inter-molecular ring-closing leads to extended four-arm “branched” peptide dimers. The latter resembles in some respects a cyclic peptide, although with a different architecture (e.g. much larger branches than the side chains on cyclic peptides) and with a distinct synthesis procedure. Regions of these peptides must retain the -sheet hydrogen bonding pattern, consistent with the XRD results presented. The conformational constraints introduced by ring-closing hinder nanotube formation, observed for the parent uncross-linked peptide. Instead, distinct fibrillar and twisted/helical ribbon self-assembled nanostructures are observed. The thickness of the fibril and ribbon structures is related to the length of the peptides, whether intra- or inter-molecularly ring-closed. Our results point towards the use of ring-closing chemistries to create novel peptide architectures, which are remarkably still able to form -sheet secondary structures.
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